# Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients

> **NCT03316534** · PHASE2 · COMPLETED · sponsor: **Azienda Ospedaliera di Perugia** · enrollment: 40 (actual)

## Conditions studied

- HIV-infected Patients

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT03316534
- **Lead sponsor:** Azienda Ospedaliera di Perugia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-02
- **Primary completion:** 2017-04-30
- **Final completion:** 2017-10-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03316534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03316534, "Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03316534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*